These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32812188)

  • 1. Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy.
    Piaserico S; Gisondi P; Cazzaniga S; Naldi L
    Am J Clin Dermatol; 2020 Oct; 21(5):749-751. PubMed ID: 32812188
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.
    Gisondi P; Facheris P; Dapavo P; Piaserico S; Conti A; Naldi L; Cazzaniga S; Malagoli P; Costanzo A
    Br J Dermatol; 2020 Aug; 183(2):373-374. PubMed ID: 32343839
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologic agents in psoriasis: our experience during coronavirus infection.
    Strippoli D; Barbagallo T; Prestinari F; Russo G; Fantini F
    Int J Dermatol; 2020 Aug; 59(8):e266-e267. PubMed ID: 32516447
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.
    Conforti C; Giuffrida R; Dianzani C; Di Meo N; Zalaudek I
    Dermatol Ther; 2020 Jul; 33(4):e13490. PubMed ID: 32358864
    [No Abstract]   [Full Text] [Related]  

  • 5. Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era.
    Galluzzo M; Tofani L; Bianchi L; Talamonti M
    Expert Opin Biol Ther; 2020 Aug; 20(8):829-830. PubMed ID: 32510244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19 infection in psoriasis patients treated with cyclosporin.
    Di Lernia V; Goldust M; Feliciani C
    Dermatol Ther; 2020 Jul; 33(4):e13739. PubMed ID: 32478942
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity and COVID-19: The clash of two pandemics.
    Chua MWJ; Zheng S
    Obes Res Clin Pract; 2020; 14(4):380-382. PubMed ID: 32631805
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical role of laboratory medicine in the global response to the COVID-19 pandemic.
    Adeli K
    Clin Chem Lab Med; 2020 Jun; 58(7):1019-1020. PubMed ID: 32484451
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.
    Magnano M; Balestri R; Bardazzi F; Mazzatenta C; Girardelli CR; Rech G
    Dermatol Ther; 2020 Jul; 33(4):e13706. PubMed ID: 32475056
    [No Abstract]   [Full Text] [Related]  

  • 10. The Novel Coronavirus Outbreak: What We Know and What We Don't.
    Cell; 2020 Mar; 180(6):1034-1036. PubMed ID: 32078801
    [No Abstract]   [Full Text] [Related]  

  • 11. Covid-19: Spiking a focus on men's health.
    Wittert G; McLachlan R
    Obes Res Clin Pract; 2020; 14(4):293-294. PubMed ID: 32828210
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
    Vick DJ
    Mayo Clin Proc; 2020 Aug; 95(8):1803-1804. PubMed ID: 32680625
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain).
    Castillo Álvarez F; López Pérez MÁ; Marzo Sola ME
    Med Clin (Barc); 2020 Oct; 155(8):362-363. PubMed ID: 32718720
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 in an elderly patient treated with secukinumab.
    Di Lernia V; Bombonato C; Motolese A
    Dermatol Ther; 2020 Jul; 33(4):e13580. PubMed ID: 32406078
    [No Abstract]   [Full Text] [Related]  

  • 15. Should biologics for psoriasis be interrupted in the era of COVID-19?
    Lebwohl M; Rivera-Oyola R; Murrell DF
    J Am Acad Dermatol; 2020 May; 82(5):1217-1218. PubMed ID: 32199889
    [No Abstract]   [Full Text] [Related]  

  • 16. Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.
    Armesto S; González Vela C; González López MA
    Dermatol Ther; 2020 Jul; 33(4):e13618. PubMed ID: 32424891
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of COVID-19 on patients with asthma.
    Pignatti P; Visca D; Cherubino F; Zampogna E; Spanevello A
    Int J Tuberc Lung Dis; 2020 Nov; 24(11):1217-1219. PubMed ID: 33172533
    [No Abstract]   [Full Text] [Related]  

  • 18. The COVID-19 Pandemic and Wildfire Smoke: Potentially Concomitant Disasters.
    Henderson SB
    Am J Public Health; 2020 Aug; 110(8):1140-1142. PubMed ID: 32552018
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronavirus infection in cancer patients, last update.
    Borregón Rivilla M; Martínez Barroso KA
    Med Clin (Barc); 2020 Oct; 155(7):299-301. PubMed ID: 32861432
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy.
    Vezzoli P; Di Mercurio M; Carugno A; Gambini DM; Robustelli Test E; Imberti G; Castagna AF; Sena P
    Dermatol Ther; 2020 Jul; 33(4):e13776. PubMed ID: 32506525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.